Boston scientific received information from a clinical study form that the patient implanted with this cardiac resynchronization therapy defibrillator (crt-d) experienced pain in the right shoulder/chest area about three weeks post-implant.A pulmonary embolism (pe) was identified and the patient was prescribed medications and released to home.The cause of the pe was unknown, but it was suspected to be related to the implanted device or the implant procedure.No additional adverse patient effects were reported.Smart registry.
|